Behavioral Interventions for Cardiovascular Disease

(BETTER P2 Trial)

AF
AL
Overseen ByAdina Lieberman
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Pennsylvania
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to improve recruitment of Black and Hispanic individuals for heart disease studies. Researchers are testing various invitation methods, such as messages that emphasize helping others, offer incentives, or highlight the prevalence of the condition. They seek to determine which methods increase participation in clinical trials. Individuals with heart disease who receive treatment at clinics with active medical records may be suitable candidates. As an unphased study, this trial provides a unique opportunity to contribute to research that could enhance recruitment strategies and increase diversity in clinical trials.

Do I need to stop my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications.

What prior data suggests that these recruitment strategies are safe for increasing trial enrollment?

Research has shown that using various communication methods and incentives to encourage clinical trial participation is generally safe. No evidence suggests that recruitment methods cause harm.

For example, studies on message framing—such as appealing to altruism or highlighting others' participation—examine their influence on behavior without reporting safety concerns. Similarly, offering small financial rewards or lottery entries has been studied for effectiveness in encouraging participation, with no mention of safety risks.

Since this trial tests recruitment strategies rather than a new medical treatment, it involves no physical risks. The trial is in the "Not Applicable" phase, focusing on strategies rather than drug safety. Therefore, participation in this type of study is considered low-risk.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores how different behavioral strategies can boost participation in cardiovascular research. Unlike typical treatments that focus on medication or surgery, this trial looks at communication techniques like appealing to altruism, using social proof, or offering incentives to see what encourages more people to join studies. By experimenting with different messaging and contact methods, researchers aim to discover the most effective ways to engage potential participants, which could lead to better representation and more robust data in future cardiovascular studies.

What evidence suggests that this trial's recruitment strategies could be effective for increasing enrollment of Black and Hispanic participants in heart disease clinical trials?

Research shows that different ways of presenting messages can encourage more people to join clinical trials. In this trial, participants will be randomized into different arms to test these strategies. One arm will use the Framing Method, appealing to altruism, which encourages helping others and can increase participation. Another arm will use social proof, highlighting that others like the participant are joining, a method proven effective in marketing studies. Additionally, some arms will offer financial incentives, such as small guaranteed payments or chances to win larger amounts, to motivate participation. The method of contact, such as receiving messages from personal clinics or research teams, will also be tested for its effect on response rates. These strategies have been studied and show promise in increasing participation, especially among under-represented groups, in important health studies.12467

Are You a Good Fit for This Trial?

This trial is for Black and Hispanic individuals with active medical records at the participating site. It aims to improve diversity in cardiovascular disease studies by testing different recruitment strategies.

Inclusion Criteria

Your medical information must be available in the hospital's electronic system.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Recruitment Strategy Testing

Testing different recruitment strategies to increase enrollment of Black and Hispanic individuals in cardiovascular cohort studies

3 weeks

Follow-up

Participants are monitored for enrollment outcomes and trust in medical researchers

3 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Framing Method (Appeal to Altruism)
  • Framing Method (Opt-Out)
  • Framing Method (Social Proof or Perceived Scarcity)
  • Incentive Structure
  • Method of Contact
  • Source of Contact
Trial Overview The study tests various methods to boost enrollment of under-represented groups in heart disease trials, including incentive structures, message framing (like social proof or scarcity), opt-out options, contact methods, and appeals to altruism.
How Is the Trial Designed?
13Treatment groups
Active Control
Group I: RCT #2, Arm #1: Source of Contact, Personal ClinicActive Control1 Intervention
Group II: RCT #3, Arm #2: Framing Method, Social ProofActive Control1 Intervention
Group III: RCT #3, Arm #3: Framing Method, No Appeal to Altruism, No Social ProofActive Control1 Intervention
Group IV: RCT #4, Arm #1: Incentive Structure, No IncentiveActive Control1 Intervention
Group V: RCT #4, Arm #2: Incentive Structure, Guarantee OnlyActive Control1 Intervention
Group VI: RCT #4, Arm #3: Incentive Structure, Guarantee + Small LotteryActive Control1 Intervention
Group VII: RCT #4, Arm #4: Incentive Structure, Mid Lottery OnlyActive Control1 Intervention
Group VIII: RCT #5, Arm #5: Incentive Structure, Large Lottery OnlyActive Control1 Intervention
Group IX: RCT #2, Arm #2: Source of Contact, Research TeamActive Control1 Intervention
Group X: RCT #3, Arm #1: Framing Method, Appeal to AltruismActive Control1 Intervention
Group XI: RCT #1, Arm #1: Contact Method, Text OnlyActive Control1 Intervention
Group XII: RCT #1, Arm #2: Contact Method, Email OnlyActive Control1 Intervention
Group XIII: RCT #1, Arm #3: Contact Method, Email+TextActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pennsylvania

Lead Sponsor

Trials
2,118
Recruited
45,270,000+

American Heart Association

Collaborator

Trials
352
Recruited
6,196,000+

Emory University

Collaborator

Trials
1,735
Recruited
2,605,000+

Published Research Related to This Trial

A significant majority (88%) of participants in a trial about MRI access for knee issues expressed interest in receiving feedback on the study results, highlighting the ethical importance of communicating findings to research volunteers.
Among those who responded to a follow-up survey, 55% preferred a longer leaflet summarizing the trial results, valuing technical information and diagrams, which suggests that detailed communication may enhance participant engagement and understanding.
Participants' preference for type of leaflet used to feed back the results of a randomised trial: a survey.Brealey, S., Andronis, L., Dennis, L., et al.[2022]
Health care providers (HCPs) are in a key position to promote physical activity (PA) as a way to prevent and treat cardiovascular disease (CVD), but many feel unprepared to tackle the challenges of encouraging behavior change.
Implementing behavioral counseling strategies can help HCPs effectively promote PA, which has the potential to significantly lower the incidence and progression of CVD in the population.
Promoting adherence to physical activity among individuals with cardiovascular disease using behavioral counseling: A theory and research-based primer for health care professionals.Williamson, TM., Moran, C., McLennan, A., et al.[2021]
In a study involving 902 patients with mild to moderate heart failure, adding self-management counseling to heart failure education did not significantly reduce the rates of death or hospitalization due to heart failure compared to education alone.
The trial, which followed patients for a median of 2.56 years, found no differences in secondary outcomes such as overall hospitalization rates or quality of life, suggesting that simply enhancing education with self-management strategies may not improve clinical outcomes.
Self-management counseling in patients with heart failure: the heart failure adherence and retention randomized behavioral trial.Powell, LH., Calvin, JE., Richardson, D., et al.[2022]

Citations

Testing Promising Behavioral Economic Interventions to ...Marketing studies have demonstrated the effectiveness of appeals to altruism, perceived scarcity ("This product is desirable because it is hard to get"), and ...
2.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/40164292/
A series of randomized trials of behavioral economic ...A series of randomized trials of behavioral economic interventions to increase racial and ethnic diversity of research participants: Rationale ...
Behavioral Interventions for Cardiovascular Disease ...The BETTER P2 medical study, being run by University of Pennsylvania, needs participants to evaluate whether Framing Method (Appeal to Altruism), ...
Framing financial incentives to promote hypertension care ...This study will determine the effectiveness of a 6-month framing financial incentive intervention in improving doctors' hypertension management.
Impact of technology-based patient education on ...Objective To collect evidence on what types of technology and content are most effective in helping people with coronary heart disease (CHD) to change their ...
Effects of message framing and risk perception on health ...The pilot study aims to elucidate the most effective risk communication strategy, utilizing message framing (gain-framed, loss-framed, or no-framed), for ...
Prospect Theory Application in Health Message Framing ...This study reports the results of two experiments designed to explore these alternative conceptualizations of risk and their effect on health decision making.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security